Important Notices This presentation contains, and our officers may make, “forward-looking” statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our management’s beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitation, information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as ‘‘anticipate,’’ ‘‘expect,’’ ‘‘suggest,’’ ‘‘plan,’’ ‘‘believe,’’ ‘‘intend,’’ ‘‘estimate,’’ ‘‘target,’’ ‘‘project,’’ ‘‘should,’’ ‘‘could,’’ ‘‘would,’’ ‘‘may,’’ ‘‘will,’’ ‘‘forecast,’’ and other similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These statements are based on certain assumptions that we have made in light of our experience in the industry and our perception of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances as of the date hereof. These and other important factors may cause our actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. As a result, we cannot guarantee future results, outcomes, levels of activity, performance, developments or achievements, and there can be no assurance that our expectations, intentions, anticipations, beliefs or projections will result or be achieved or accomplished. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in the our Annual Report on Form 10-K for the year ended December 31, 2017 as filed with the Securities and Exchange Commission (the “SEC”) and our subsequent filings with the SEC. The forward-looking statements in this presentation are made only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. This presentation also contains estimates and other statistical data made by independent parties and by us relating to market size and growth and other data about our industry. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. The financial information of Advance Medical-Health Care Management Services, S.A. ("Advance Medical") presented herein has been derived from the audited consolidated financial statements of Advance Medical, which were prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board. Such preparation may result in material differences from a financial presentation prepared under GAAP. We expect to file with the SEC the financial statements of Advance Medical as required by Form 8-K and within the time provided therein. This presentation also includes the Adjusted EBITDA of Advance Medical for 2017, which is a non-IFRS financial measure as defined by SEC rules. We believe that the presentation of Adjusted EBITDA enhances an investor's understanding of Advance Medical's financial performance. Advance Medical's management has used Adjusted EBITDA for business planning purposes and in measuring the performance of Advanced Medical relative to its competitors. For a reconciliation of Advance Medical's Adjusted EBITDA to the most directly comparable financial measure calculated according to IFRS, refer to the Appendix to this presentation.
